Your browser doesn't support javascript.
loading
LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients.
Mock, Andreas; Geisenberger, Christoph; Orlik, Christian; Warta, Rolf; Schwager, Christian; Jungk, Christine; Dutruel, Céline; Geiselhart, Lea; Weichenhan, Dieter; Zucknick, Manuela; Nied, Ann-Katrin; Friauf, Sara; Exner, Janina; Capper, David; Hartmann, Christian; Lahrmann, Bernd; Grabe, Niels; Debus, Jürgen; von Deimling, Andreas; Popanda, Odilia; Plass, Christoph; Unterberg, Andreas; Abdollahi, Amir; Schmezer, Peter; Herold-Mende, Christel.
Afiliação
  • Mock A; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Geisenberger C; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Orlik C; Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Warta R; Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg Ion Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Schwager C; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Jungk C; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Dutruel C; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Geiselhart L; Molecular and Translational Radiation Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weichenhan D; Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg Ion Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Zucknick M; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Nied AK; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Friauf S; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Exner J; Division of Epigenomics and Cancer Risk Factors, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Capper D; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hartmann C; Oslo Center for Biostatistics and Epidemiology, Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
  • Lahrmann B; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Grabe N; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany.
  • von Deimling A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Popanda O; German Cancer Consortium (DKTK), Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DFKZ), Heidelberg, Germany.
  • Plass C; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.
  • Unterberg A; Department of Neuropathology, Institute of Pathology, Hannover Medical School, Hannover, Germany.
  • Abdollahi A; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University of Heidelberg, Heidelberg, Germany.
  • Schmezer P; National Center for Tumor Diseases (NCT), Medical Oncology, Heidelberg University Hospital, Heidelberg, Germany.
  • Herold-Mende C; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Int J Cancer ; 139(2): 424-32, 2016 07 15.
Article em En | MEDLINE | ID: mdl-26934681

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Regiões Promotoras Genéticas / Glioblastoma / Metilação de DNA / Isocitrato Desidrogenase Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Regiões Promotoras Genéticas / Glioblastoma / Metilação de DNA / Isocitrato Desidrogenase Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha
...